These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38779109)

  • 41. Tenecteplase versus alteplase for the treatment of acute ischemic stroke: a meta-analysis of randomized controlled trials.
    Huang J; Zheng H; Zhu X; Zhang K; Ping X
    Ann Med; 2024 Dec; 56(1):2320285. PubMed ID: 38442293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials.
    Xu N; Chen Z; Zhao C; Xue T; Wu X; Sun X; Wang Z
    Drug Des Devel Ther; 2018; 12():2071-2084. PubMed ID: 30013325
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Implementation of Tenecteplase for Acute Ischemic Stroke Treatment.
    Brown CS; Manuel FC; Mattson AE; Schmitt CJ; Hellickson JD; Clark SL; Wieruszewski ED
    J Emerg Nurs; 2024 Mar; 50(2):171-177. PubMed ID: 38069957
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tenecteplase for Acute Ischemic Stroke Thrombolysis: Practical Considerations and Real-World Implementation.
    Streib C
    Neurol Clin Pract; 2024 Feb; 14(1):e200221. PubMed ID: 38223783
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Switching to Tenecteplase for Stroke Thrombolysis: Real-World Experience and Outcomes in a Regional Stroke Network.
    Mahawish K; Gommans J; Kleinig T; Lallu B; Tyson A; Ranta A
    Stroke; 2021 Oct; 52(10):e590-e593. PubMed ID: 34465202
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tenecteplase or Alteplase Better in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion: A Single Center Observational Study.
    Teivane A; Jurjāns K; Vētra J; Grigorjeva J; Kupcs K; Masiliūnas R; Miglāne E
    Medicina (Kaunas); 2022 Aug; 58(9):. PubMed ID: 36143846
    [No Abstract]   [Full Text] [Related]  

  • 47. Evolving Thrombolytics: from Alteplase to Tenecteplase.
    Miller SE; Warach SJ
    Neurotherapeutics; 2023 Apr; 20(3):664-678. PubMed ID: 37273127
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comprehensive Review of Tenecteplase for Thrombolysis in Acute Ischemic Stroke.
    Wang L; Hao M; Wu N; Wu S; Fisher M; Xiong Y
    J Am Heart Assoc; 2024 May; 13(9):e031692. PubMed ID: 38686848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tenecteplase versus alteplase for acute ischemic stroke: a systematic review and meta-analysis of randomized and non-randomized studies.
    Ma Y; Xiang H; Busse JW; Yao M; Guo J; Ge L; Li B; Luo X; Mei F; Liu J; Wang Y; Liu Y; Li W; Zou K; Li L; Sun X
    J Neurol; 2024 May; 271(5):2309-2323. PubMed ID: 38436679
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thrombolysis for acute ischaemic stroke with alteplase in an Asian population: results of the multicenter, multinational Safe Implementation of Thrombolysis in Stroke-Non-European Union World (SITS-NEW).
    Rha JH; Shrivastava VP; Wang Y; Lee KE; Ahmed N; Bluhmki E; Hermansson K; Wahlgren N;
    Int J Stroke; 2014 Oct; 9 Suppl A100():93-101. PubMed ID: 22988894
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tenecteplase versus alteplase in acute ischemic stroke: systematic review and meta-analysis.
    Thelengana A; Radhakrishnan DM; Prasad M; Kumar A; Prasad K
    Acta Neurol Belg; 2019 Sep; 119(3):359-367. PubMed ID: 29728903
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety outcomes of Tenecteplase versus Alteplase for thrombolysis of acute ischemic stroke: A meta-analysis of 9 randomized controlled trials.
    Wang Y; Cai X; Fang Q; Zhu J
    J Neurol Sci; 2024 Mar; 458():122912. PubMed ID: 38325064
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcomes associated to the time to treatment with intravenous tenecteplase for acute ischaemic stroke: subgroup analysis of the TRACE-2 randomised controlled clinical trial.
    Li S; Wangqin R; Pan Y; Jin A; Li H; Schwamm LH; Fisher M; Campbell BCV; Parsons MW; Wang Z; Dai H; Li D; Li R; Wang J; Wang D; Wang Y; Zhao X; Li Z; Zheng H; Xiong Y; Meng X; Wang Y
    Stroke Vasc Neurol; 2024 Jan; ():. PubMed ID: 38296586
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Using Tenecteplase for Acute Ischemic Stroke: What Is the Hold Up?
    Zitek T; Ataya R; Brea I
    West J Emerg Med; 2020 Feb; 21(2):199-202. PubMed ID: 32191176
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute ischemic stroke: imaging-guided tenecteplase treatment in an extended time window.
    Parsons MW; Miteff F; Bateman GA; Spratt N; Loiselle A; Attia J; Levi CR
    Neurology; 2009 Mar; 72(10):915-21. PubMed ID: 19273826
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcomes with IV tenecteplase and IV alteplase for acute ischemic stroke with or without thrombectomy in real-world settings in the United States.
    Qureshi AI; Baskett WI; Bains NK; French BR; Siddiq F; Gomez CR; Shyu CR
    J Stroke Cerebrovasc Dis; 2023 Feb; 32(2):106898. PubMed ID: 36493706
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit-TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unit.
    Bivard A; Zhao H; Coote S; Campbell B; Churilov L; Yassi N; Yan B; Valente M; Sharobeam A; Balabanski A; Dos Santos A; Ng F; Langenberg F; Stephenson M; Smith K; Bernard S; Thijs V; Cloud G; Choi P; Ma H; Wijeratne T; Chen C; Olenko L; Davis SM; Donnan GA; Parsons M
    BMJ Open; 2022 Apr; 12(4):e056573. PubMed ID: 35487712
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of tenecteplase in comparison to alteplase in acute ischemic stroke: A systematic review and meta-analysis of randomized controlled trials.
    Salamatullah HK; Bashrahil B; Alghamdi AM; Alsharm FS; Alkulli OA; Alzahrani Z; Alkhiri A; Alghamdi S; Makkawi S
    Clin Neurol Neurosurg; 2023 Oct; 233():107961. PubMed ID: 37713743
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tenecteplase versus alteplase for large vessel occlusion recanalization (T-FLAVOR): Trial protocol.
    Kawano H; Hirano T; Inoue M; Fukuda-Doi M; Iwasaki K; Omae K; Tanaka K; Yamamoto H; Koga M; Sakai N; Nagao T; Sasaki M; Hayakawa N; Toyoda K
    Eur Stroke J; 2022 Mar; 7(1):71-75. PubMed ID: 35300254
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coagulation and Fibrinolytic Activity of Tenecteplase and Alteplase in Acute Ischemic Stroke.
    Huang X; Moreton FC; Kalladka D; Cheripelli BK; MacIsaac R; Tait RC; Muir KW
    Stroke; 2015 Dec; 46(12):3543-6. PubMed ID: 26514192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.